Perghaps I missed it. I was aware that because they changed the contrast for the oral cancer trial the FDA wanted them to gaher more data and resubmit via a different pathway. But this is different, since there seem to additional regulatory changes to meet in addition to the other work that the company has already completed on contrast agents?
- Forums
- ASX - By Stock
- Ann: OIL June 2024 Quarterly Report and Appendix 4C
Perghaps I missed it. I was aware that because they changed the...
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add OIL (ASX) to my watchlist
(20min delay)
|
|||||
Last
17.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $142.0M |
Open | High | Low | Value | Volume |
17.0¢ | 17.0¢ | 17.0¢ | $2.719K | 15.99K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 10000 | 16.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
17.0¢ | 5969 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 10000 | 0.165 |
2 | 68020 | 0.160 |
3 | 33026 | 0.155 |
6 | 81299 | 0.150 |
1 | 5000 | 0.145 |
Price($) | Vol. | No. |
---|---|---|
0.170 | 5969 | 2 |
0.175 | 34261 | 1 |
0.180 | 123689 | 3 |
0.185 | 132650 | 4 |
0.190 | 30000 | 1 |
Last trade - 12.12pm 14/11/2024 (20 minute delay) ? |
Featured News
OIL (ASX) Chart |